Literature DB >> 19040616

Synergistic effects of cyclic strain and Th1-like cytokines on tenascin-C production by rheumatic aortic valve interstitial cells.

L Jiang1, X F Wei, D H Yi, P Xu, H Liu, Q Chang, S M Yang, Z F Li, H B Gao, G J Hao.   

Abstract

Tenascin-C (TN-C) is a key component of extracellular matrix (ECM) and its expression process is poorly understood during rheumatic heart valvular disease (RHVD). In this study, we found that interferon (IFN)-gamma, tumour necrosis factor (TNF)-alpha and TN-C concentrations in patients with RHVD were significantly higher than in normal controls. More IFN-gamma receptors and TNF receptors were found being expressed on rheumatic aortic valves interstitial cells than on non-rheumatic ones and their expression was patients' sera dependent. Antibodies neutralizing IFN-gamma or TNF-alpha could attenuate patients' sera-induced TN-C transcription by isolated rheumatic aortic valves interstitial cells. By application with different protein kinase inhibitors, we found that combined with cyclic strain, TNF-alpha and IFN-gamma induced TN-C transcription through the RhoA/ROCK signalling pathway. At the same time, p38 mitogen-activated protein kinase was involved in TNF-alpha and IFN-gamma induced TN-C transcription. TNF-alpha also increased TN-C mRNA level by additional PKC and ERK 1/2 activation. Our finding revealed a new insight into ECM remodelling during RHVD pathogenesis and new mechanisms involved in the clinical anti-IFN-gamma and anti-TNF-alpha therapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19040616      PMCID: PMC2675252          DOI: 10.1111/j.1365-2249.2008.03747.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  28 in total

1.  Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis.

Authors:  B Jian; P L Jones; Q Li; E R Mohler; F J Schoen; R J Levy
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

2.  Progression of human aortic valve stenosis is associated with tenascin-C expression.

Authors:  Jari Satta; Jukka Melkko; Raimo Pöllänen; Juha Tuukkanen; Paavo Pääkkö; Pasi Ohtonen; Ari Mennander; Ylermi Soini
Journal:  J Am Coll Cardiol       Date:  2002-01-02       Impact factor: 24.094

Review 3.  Protein kinase C isozymes as potential therapeutic targets in immune disorders.

Authors:  Matthew R Lee; Wei Duan; Seng-Lai Tan
Journal:  Expert Opin Ther Targets       Date:  2008-05       Impact factor: 6.902

Review 4.  Tenascin-C in development and disease: gene regulation and cell function.

Authors:  P L Jones; F S Jones
Journal:  Matrix Biol       Date:  2000-12       Impact factor: 11.583

5.  Randomized, double-blind trial of anti-interferon-gamma antibodies in rheumatoid arthritis.

Authors:  Y A Sigidin; G V Loukina; B Skurkovich; S Skurkovich
Journal:  Scand J Rheumatol       Date:  2001       Impact factor: 3.641

6.  Rheumatic heart disease: proinflammatory cytokines play a role in the progression and maintenance of valvular lesions.

Authors:  Luiza Guilherme; Patricia Cury; Lea M F Demarchi; Verônica Coelho; Lúcia Abel; Ana P Lopez; Sandra Emiko Oshiro; Selma Aliotti; Edécio Cunha-Neto; Pablo M A Pomerantzeff; Ana C Tanaka; Jorge Kalil
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

7.  Ets-1 regulates TNF-alpha-induced matrix metalloproteinase-9 and tenascin expression in primary bronchial fibroblasts.

Authors:  Yutaka Nakamura; Stéphane Esnault; Takashi Maeda; Elizabeth A B Kelly; James S Malter; Nizar N Jarjour
Journal:  J Immunol       Date:  2004-02-01       Impact factor: 5.422

8.  Thymosin beta4 regulation, expression and function in aortic valve interstitial cells.

Authors:  Quan-Yi Li; Peter L Jones; Robert P Lafferty; Daniel Safer; Robert J Levy
Journal:  J Heart Valve Dis       Date:  2002-09

Review 9.  Matricellular proteins in the heart: possible role during stress and remodeling.

Authors:  Mark W M Schellings; Yigal M Pinto; Stephane Heymans
Journal:  Cardiovasc Res       Date:  2004-10-01       Impact factor: 10.787

10.  Induction of tenascin-C by cyclic tensile strain versus growth factors: distinct contributions by Rho/ROCK and MAPK signaling pathways.

Authors:  Matthias Chiquet; Ana Sarasa-Renedo; Vildan Tunç-Civelek
Journal:  Biochim Biophys Acta       Date:  2004-09-17
View more
  10 in total

1.  Tenascin-C produced by oxidized LDL-stimulated macrophages increases foam cell formation through Toll-like receptor-4.

Authors:  Rui Liu; Yong He; Bo Li; Jun Liu; Yingang Ren; Wei Han; Xing Wang; Lihua Zhang
Journal:  Mol Cells       Date:  2012-06-12       Impact factor: 5.034

2.  Polymethoxy flavones do not exert an inducing effect on the biosynthesis and secretion of insulin by pancreatic β-cells.

Authors:  Hao Dong; Hong-Dong Chen; Yi-Jun Zhao; Hong-Min Li
Journal:  Biomed Rep       Date:  2014-01-16

3.  Attenuated expression of tenascin-C in ovalbumin-challenged STAT4-/- mice.

Authors:  Anna Meuronen; Piia Karisola; Marina Leino; Terhi Savinko; Kristiina Sirola; Marja-Leena Majuri; Päivi Piirilä; Ismo Virtanen; Mika Mäkelä; Annika Laitinen; Lauri A Laitinen; Harri Alenius
Journal:  Respir Res       Date:  2011-01-04

Review 4.  Advances in tenascin-C biology.

Authors:  Kim S Midwood; Thomas Hussenet; Benoit Langlois; Gertraud Orend
Journal:  Cell Mol Life Sci       Date:  2011-08-05       Impact factor: 9.261

Review 5.  Revisiting the matricellular concept.

Authors:  Joanne E Murphy-Ullrich; E Helene Sage
Journal:  Matrix Biol       Date:  2014-07-24       Impact factor: 11.583

6.  Rheumatic Heart Disease and Myxomatous Degeneration: Differences and Similarities of Valve Damage Resulting from Autoimmune Reactions and Matrix Disorganization.

Authors:  Carlo de Oliveira Martins; Lea Demarchi; Frederico Moraes Ferreira; Pablo Maria Alberto Pomerantzeff; Carlos Brandao; Roney Orismar Sampaio; Guilherme Sobreira Spina; Jorge Kalil; Edecio Cunha-Neto; Luiza Guilherme
Journal:  PLoS One       Date:  2017-01-25       Impact factor: 3.240

Review 7.  Signalling pathways implicated in the pathogenesis of rheumatic heart disease (Review).

Authors:  Shenglin Xian; Zhiyu Zeng
Journal:  Exp Ther Med       Date:  2020-11-25       Impact factor: 2.447

8.  mTOR signal transduction pathways contribute to TN-C FNIII A1 overexpression by mechanical stress in osteosarcoma cells.

Authors:  Lianhe Zheng; Dianzhong Zhang; Yunfei Zhang; Yanhua Wen; Yucai Wang
Journal:  Mol Cells       Date:  2014-02-19       Impact factor: 5.034

9.  An investigation of tenascin-C levels in rheumatic mitral stenosis and their response to percutaneous mitral balloon valvuloplasty.

Authors:  Ahmet Celik; Ozgur Gunebakmaz; Oguzhan Baran; Orhan Dogdu; Deniz Elcik; Mehmet Ali Kobat; Mehmet Balin; Kenan Erdem; Suleyman Aydin; Ibrahim Ozdogru; Ramazan Topsakal
Journal:  Med Princ Pract       Date:  2012-08-08       Impact factor: 1.927

10.  Interference with the expression of S1PR1 or STAT3 attenuates valvular damage due to rheumatic heart disease.

Authors:  Shenglin Xian; Ang Chen; Yunjiao Wu; Hong Wen; Chuanghong Lu; Feng Huang; Zhiyu Zeng
Journal:  Int J Mol Med       Date:  2021-07-23       Impact factor: 4.101

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.